Michel Detheux has succeeded Rita Balice-Gordon as CEO of Danish neuro biotech Muna Therapeutics.
July 2, 2026 07:00 AM EDT
Peer Review
Ex-iTeos CEO starts fresh at GSK neuro partner; Genentech loses yet another key scientist
Alex Hoffman
Copy Chief and News Editor
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
Le Belge Michel Detheux, ex-patron d’Iteos Therapeutics, la biotech aujourd’hui disparue, prend la tête de Muna Therapeutics. Une…
When Belén Garijo, M.D., Ph.D., left the top job at Germany’s Merck KGaA to head over to Sanofi, she was inheriting a company in…
Thomas Lampron formally announced on LinkedIn this week that he is 'thrilled to join the powerhouse team at Revolution Medicines'…
Silvia Luque announced on LinkedIn that she was named head of US marketing at Zealand Pharma. She had been executive director of…
Immunic (IMUX) stock rises premarket to $13.14 as the company names former Genentech executive Erik Lundgren as CEO. See how his…
Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances
Michel Detheux nommé CEO de Muna Therapeutics, spécialiste du traitement contre Alzheimer
Investors double down on Bain-backed startup
Roche drug sets new standard for KRAS-driven lung cancer
